Toenail Fungus Treatment Extra Strength Pen Dailymed
Generic: tolnaftate, undecylenic acid
Go PRO for all pill images
Toenail Fungus Treatment Extra Strength Pen
Otc - Active Ingredient Section
TOLNAFTATE 1% UNDECYLENIC ACID 25%
Otc - Purpose Section
Anti-fungal
Indications & Usage Section
For the effective treatment of nail fungus,discoloration,thick-ening,splitting,crumbling and brittleness.
Warnings Section
For external use only.
Otc - Do Not Use Section
children under 2 years of age. pregnant or if there is any allergic reaction to this produce.
Otc - When Using Section
Avoid contact with eyes. in case of contact, rinse thoroughly with water.
Otc - Stop Use Section
lrritation occurs or discomfort persists.
Otc - Keep Out Of Reach Of Children Section
In case of accidental ingestion, seek medical advice immediately or contact a Poison Control center right away.
Dosage & Administration Section
Wash and dry your nails before use, Remove the capcovering the brush of the pen. Twist the end of the pen clockwise to dispense the liquidonto the brush. Apply the liquid 3 times over the areas that need to berepalred, and make sure to cover all affected parts. Use 2-3 times daily for 2-4 week s, depending on thecondition of the area that needs repair.
Storage And Handling Section
Store between 15° to 30 °C (59 °to 86 °F)Avoid freezing andexcessive heat above 40C°(104F).
Inactive Ingredient Section
ALCOHOL DIMETHICONE CETOSTEARYL ALCOHOL TEA TREE OIL PROPYLENE GLYCOL TOCOPHEROL SAFFLOWER OIL WATER
Package Label.principal Display Panel
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
